Sign in

CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Sionna Therapeutics, Inc.

Sign in to watch
Ticker
SION
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-819-2020
Business address
21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
  1. 4 Planned sale Chief Legal Officer sold 10,250 shares at $40.52 ($415,330)
  2. 4 Planned sale Director sold 108,073 shares at an average $44.55 ($4,814,205)
  3. 4 Planned sale Director sold 108,073 shares at an average $44.55 ($4,814,205)
  4. 4 Open-market sale Director sold 30,316 shares at an average $39.61 ($1,200,704)
  5. 4 Open-market sale Director sold 136,351 shares at an average $40.34 ($5,500,158)
  6. 4 Open-market sale Director sold 373,610 shares at an average $39.51 ($14,762,604)
  7. 4 Planned sale President & CEO sold 99,800 shares at an average $36.26 ($3,618,560)
  8. 4 Planned sale Director sold 88,878 shares at an average $34.22 ($3,041,683)
  9. 4 Planned sale Director sold 286,369 shares at an average $32.30 ($9,251,102)
  10. 4 Planned sale President & CEO sold 25,200 shares at an average $31.28 ($788,153)
  11. 4 Planned sale Director sold 194,932 shares at an average $30.47 ($5,939,784)
  12. 4 Planned sale Director sold 49,546 shares at an average $29.99 ($1,485,790)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale Director sold 78,693 shares at an average $30.08 ($2,367,473)
  16. 4 Planned sale President & CEO sold 25,000 shares at an average $29.11 ($727,798)
  17. 4 Planned sale Chief Legal Officer sold 10,250 shares at $23.12 ($236,980)
  18. 4 Planned sale CFO & Head of Corp. Dev. sold 9,584 shares at an average $25.09 ($240,442)
  19. 4 Planned sale President & CEO sold 25,000 shares at an average $24.97 ($624,361)
  20. 4 Planned sale CFO & Head of Corp. Dev. sold 23,416 shares at an average $25.70 ($601,858)

Page 3 of 5 · 100 filings